Feng, Xiaodong_ Xie, Hong-Guang - Applying pharmacogenomics in therapeutics-CRC Press (2016)

Essential Pharmacogenomic Biomarkers in Clinical Practice
67
REFERENCES
1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized
patients: A meta-analysis of prospective studies. JAMA 1998;279:1200–5.
2. Bonita R, Pradhan R. Cardiovascular toxicities of cancer chemotherapy. Seminars in
Oncology 2013;40:156–67.
3. Perazella MA, Moeckel GW. Nephrotoxicity from chemotherapeutic agents: Clinical
manifestations, pathobiology, and prevention/therapy. Seminars in Nephrology
2010;30:570–81.
4. Grisold W, Cavaletti G, Windebank AJ. Peripheral neuropathies from chemotherapeutics
and targeted agents: Diagnosis, treatment, and prevention. Neuro-Oncology
2012;14(Suppl 4):iv45–54.
5. Thatishetty AV, Agresti N, O’Brien CB. Chemotherapy-induced hepatotoxicity. Clinics
in Liver Disease 2013;17:671–86, ix–x.
6. Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/American
College of Cardiology Foundation guide to warfarin therapy. Journal of the American
College of Cardiology 2003;41:1633–52.
7. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human
genome. Nature 2001;409:860–921.
8. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science
2001;291:1304–51.
9. Vaquero MP, Sanchez Muniz FJ, Jimenez Redondo S, Prats Olivan P, Higueras FJ,
Bastida S. Major diet-drug interactions affecting the kinetic characteristics and hypolipidaemic
properties of statins. Nutricion Hospitalaria 2010;25:193–206.
10. Rosenberg B, VanCamp L, Trosko JE, Mansour VH. Platinum compounds: A new class
of potent antitumour agents. Nature 1969;222:385–6.
11. Dolan ME, Newbold KG, Nagasubramanian R, et al. Heritability and linkage analysis
of sensitivity to cisplatin-induced cytotoxicity. Cancer Research 2004;64:4353–6.
12. Shukla SJ, Duan S, Badner JA, Wu X, Dolan ME. Susceptibility loci involved in cisplatininduced
cytotoxicity and apoptosis. Pharmacogenetics and Genomics 2008;18:253–62.
13. Mardis ER. The impact of next-generation sequencing technology on genetics. Trends
in Genetics 2008;24:133–41.
14. Mardis ER. Next-generation DNA sequencing methods. Annual Review of Genomics
and Human Genetics 2008;9:387–402.
15. Abecasis GR, Altshuler D, Auton A, et al. A map of human genome variation from
population-scale sequencing. Nature 2010;467:1061–73.
16. Watkins WS, Rogers AR, Ostler CT, et al. Genetic variation among world populations:
Inferences from 100 Alu insertion polymorphisms. Genome Research 2003;13:1607–18.
17. HapMap. The International HapMap Project. Nature 2003;426:789–96.
18. HapMap. A haplotype map of the human genome. Nature 2005;437:1299–320.
19. Hindorff LA, Sethupathy P, Junkins HA, et al. Potential etiologic and functional implications
of genome-wide association loci for human diseases and traits. Proceedings of
the National Academy of Sciences of the United States of America 2009;106:9362–7.
20. Spielman RS, Bastone LA, Burdick JT, Morley M, Ewens WJ, Cheung VG. Common
genetic variants account for differences in gene expression among ethnic groups.
Nature Genetics 2007;39:226–31.
21. Stranger BE, Nica AC, Forrest MS, et al. Population genomics of human gene expression.
Nature Genetics 2007;39:1217–24.
22. Duan S, Huang RS, Zhang W, et al. Genetic architecture of transcript-level variation in
humans. American Journal of Human Genetics 2008;82:1101–13.
23. Morley M, Molony CM, Weber TM, et al. Genetic analysis of genome-wide variation
in human gene expression. Nature 2004;430:743–7.